accessibility menu, dialog, popup

UserName
Viewing profile as user:

Hamster Secondary Antibodies

Secondary antibodies where hamster is the host species. Secondary antibodies must be raised against the host species of the primary antibody. Includes different antigens, classifications, conjugations, and isotypes.
Applications 
  • (1)
  • (1)
  • (1)
  • (1)
Classification 
  • (2)
Conjugate 
  • (2)
Form 
  • (2)
Host Species 
  • (1)
  • (1)

Filtered Search Results

Products from some of our suppliers do not display in filtered search results. Please clear all filters to see these products.

Narrow Results

Narrow Results

category

brands

  • (1)
  • (2)

special interests

  • (1)
  • (1)

Applications

  • (1)
  • (1)
  • (1)
  • (1)

Classification

  • (2)

Conjugate

  • (2)

Form

  • (2)

Host Species

  • (1)
  • (1)

Isotype

  • (1)
  • (1)

Quantity

  • (2)

Regulatory Status

  • (2)

Target Species

  • (1)
  • (2)

Search Within Results
Keyword Search:
1 – 3 of 3 results
1

Invitrogen™ CTLA-4 Recombinant Rabbit Monoclonal Antibody (R3P1-E11)

Rabbit Recombinant Monoclonal Antibody

EDGE ENCOMPASS_PREFERRED
Content And Storage Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Target Species Human
Host Species Rabbit
Conjugate Unconjugated
Applications Flow Cytometry,Immunohistochemistry (Paraffin),Immunocytochemistry
Form Liquid
Gene Accession No. P16410
Isotype IgG λ
Concentration 1 mg/mL
Antigen CTLA-4
Gene Symbols CTLA4
Regulatory Status RUO
Purification Method Protein A
Gene Alias ALPS5; CD; CD152; CD152 antigen; CD152 isoform; CD152 protein; CD152 protein precursor; celiac disease 3; CELIAC3; Ctla4; CTLA-4; cytotoxic T lymphocyte associated antigen 4 short spliced form; cytotoxic T-lymphocyte associated protein 4; cytotoxic T-lymphocyte protein 4; cytotoxic T-lymphocyte protein 4 isoform CTLA4-TM; cytotoxic T-lymphocyte-associated antigen 4; cytotoxic T-lymphocyte-associated protein 4; cytotoxic T-lymphocyte-associated serine esterase-4; EGK_04712; GRD4; GSE; ICOS; IDDM12; insulin-dependent diabetes mellitus 12; ligand and transmembrane spliced cytotoxic T lymphocyte associated antigen 4; Ly-56; sCTLA4; soluble form; transmembrane form
Gene CTLA4
Product Type Antibody
Gene ID (Entrez) 1493
Formulation PBS with 0.09% sodium azide; pH 7.2-7.4
Immunogen Protein corresponding to human CTLA-4 [aa1-aa161].
Classification Recombinant Monoclonal
Primary or Secondary Primary
Clone R3P1-E11
2

Invitrogen™ CTLA-4 Recombinant Human Monoclonal Antibody (12E8)
GREENER_CHOICE

Human Recombinant Monoclonal Antibody

ENCOMPASS_PREFERRED
Content And Storage -20°C or -80°C if preferred
Target Species Human,Bacteria
Host Species Human
Conjugate Unconjugated
Applications ELISA
Form Liquid
Gene Accession No. P16410
Isotype IgG1
Concentration 1 mg/mL
Antigen CTLA-4
Gene Symbols CTLA4
Regulatory Status RUO
Purification Method Affinity chromatography
Gene Alias ALPS5; CD; CD152; CD152 antigen; CD152 isoform; CD152 protein; CD152 protein precursor; celiac disease 3; CELIAC3; Ctla4; CTLA-4; cytotoxic T lymphocyte associated antigen 4 short spliced form; cytotoxic T-lymphocyte associated protein 4; cytotoxic T-lymphocyte protein 4; cytotoxic T-lymphocyte protein 4 isoform CTLA4-TM; cytotoxic T-lymphocyte-associated antigen 4; cytotoxic T-lymphocyte-associated protein 4; cytotoxic T-lymphocyte-associated serine esterase-4; EGK_04712; GRD4; GSE; ICOS; IDDM12; insulin-dependent diabetes mellitus 12; ligand and transmembrane spliced cytotoxic T lymphocyte associated antigen 4; Ly-56; sCTLA4; soluble form; transmembrane form
Gene CTLA4
Product Type Antibody
Gene ID (Entrez) 1493
Formulation PBS with 50% glycerol and 0.03% ProClin 300; pH 7.4
Immunogen Recombinant Human proetin L protein.
Classification Recombinant Monoclonal
Primary or Secondary Primary
Clone 12E8
3

Apexbio Technology LLC Anti-CTLA-4/CD152 Antibody (Ipilimumab) 5mg

Ipilimumab (CAS 477202-00-9) is a fully human monoclonal antibody targeting cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4/CD152) an inhibitory receptor expressed on activated T cells It is designed to block the interaction between CTLA-4 and its ligands CD80/CD86 thereby modulating inhibitory signaling pathways affecting T cell-mediated immune responses Ipilimumab exerts its biological activity primarily through specific binding to CTLA-4 thus regulating immune checkpoint signaling Based on these pharmacological properties Ipilimumab holds research potential in studies focusing on CTLA-4-mediated immune regulation and investigative models addressing unresectable or metastatic melanoma

ENCOMPASS_PREFERRED